List of works - Walid S Kamoun

Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas

scientific article

Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.

scientific article

Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery

scientific article

Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.

scientific article published on 4 April 2016

Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice

scientific article

Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation ⬇️

scientific article published on February 14, 2011

Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells.

scientific article

Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape

scientific article

In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model

scientific article

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner

scientific article

Quantum dot/antibody conjugates for in vivo cytometric imaging in mice

scientific article

Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation

scientific article

Scaling rules for diffusive drug delivery in tumor and normal tissues

scientific article

Sensitivity of MRI tumor biomarkers to VEGFR inhibitor therapy in an orthotopic mouse glioma model

scientific article (publication date: 3 March 2011)

Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks

scientific article

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

scientific article

List of works by Walid S Kamoun

Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas

Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.

Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery

Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.

Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice

Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation ⬇️

Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells.

Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape

In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner

Quantum dot/antibody conjugates for in vivo cytometric imaging in mice

Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation

Scaling rules for diffusive drug delivery in tumor and normal tissues

Sensitivity of MRI tumor biomarkers to VEGFR inhibitor therapy in an orthotopic mouse glioma model

Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy